Mizuho Securities Usa LLC Biomarin Pharmaceutical Inc Transaction History

Mizuho Securities Usa LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 31, 2019	SELL	$67.4 - $85.11 $1.31 Million - $1.66 Million	-19,500 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$80.35 - $93.9 $354,825 - $414,662	4,416 Added 29.28%	19,500 $1.67 Million
Q1 2019 Apr 24, 2019	SELL	$84.2 - $98.62 $857,998 - $1 Million	-10,190 Reduced 40.32%	15,084 $1.34 Million
Q4 2018 Feb 04, 2019	BUY	$80.14 - $106.07 $1.07 Million - $1.42 Million	13,371 Added 112.33%	25,274 $2.15 Million
Q3 2018 Oct 18, 2018	BUY	$93.92 - $105.72 $1.12 Million - $1.26 Million	11,903 New	11,903 $1.15 Million

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Mizuho Securities Usa LLC, based on Form 13F filings with the SEC.

Stay updated on Mizuho Securities Usa LLC with notifications on news.